Two mutations team up to cloak a deadly brain cancer from the immune system, study suggests
A new study of glioblastoma suggests that two specific cancer cell mutations may work together to help hide tumors from the immune system.
All Posts by
A new study of glioblastoma suggests that two specific cancer cell mutations may work together to help hide tumors from the immune system.
In an OncLive podcast, Drs. Milner, Dalal and Ligon discussed stem cell transplant methods, results and risk factors in pediatric patients.
UF Health Cancer Center members in the department of health outcomes and bioinformatics are working to create an AI-enabled learning health system.
In an interview with OncLive, John Ligon, M.D., discussed findings from a study on the use of mediports to deliver CAR T-cell therapy.
Bently Doonan, M.D., M.S., is one of the Cancer Center's clinical investigators who has dedicated his career to developing better cancer treatments.
Ramzi Salloum, Ph.D., was selected to chair the Learning Healthcare Systems as Natural Laboratories action group.
UF Health joins a national effort to implement innovative health strategies to improve patient outcomes.
The UF Cardio-Oncology Symposium on March 1 brought together UF faculty, staff and students to foster new collaborations.
The team will study the role of the gut microbiome in prostate cancer.
In an interview with OncLive, Jonathan Chatzkel, M.D., discussed the phase Ib/II IMMCO-1 trial in mCRPC and other immunologically cold tumors.